FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
4/16/2013 10:56:42 AM
More...
|
Charleston Laboratories, Inc. Begins Enrollment for CL-108 Phase 3 Clinical Trial
1/28/2013 10:35:55 AM
More...
|
Charleston Laboratories, Inc. Awarded a Qualifying Therapeutic Discovery Project (QTDP) Grant Under the U.S. Patient Protection and Affordable Care Act of 2010
11/3/2010 7:10:42 AM
More...
|
Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
5/18/2009 2:40:36 PM
More...
|
Charleston Laboratories, Inc. Phase I Clinical Trial
2/3/2009 8:57:06 AM
More...
|
Charleston Laboratories, Inc. Phase I Clinical Trial
2/3/2009 8:22:02 AM
More...
|
Charleston Laboratories, Inc. Phase I Clinical Trial
1/12/2009 9:02:38 AM
More...
|